← Back to Analyst Consensus 
BLFS Hold
BIOLIFE SOLUTIONS INC
Current Price —
Implied Upside —
Analysts 15
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 4, 2026 (9 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 10, 2026 | Benchmark | downgrade | Buy → Hold | — | 54% |
| Jul 27, 2026 | Stephens & Co. | downgrade | Overweight → Equal-Weight | — | 54% |
| Jul 23, 2026 | Jefferies | downgrade | Buy → Hold | — | 52% |
| Jul 23, 2026 | TD Cowen | downgrade | Buy → Hold | — | 54% |
| Jul 22, 2026 | Lake Street | downgrade | Buy → Hold | — | 47% |
| Jul 22, 2026 | HC Wainwright & Co. | downgrade | Buy → Neutral | — | 44% |
| Dec 29, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $32 | 44% |
| Nov 24, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $32 | 44% |
| Aug 8, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $32 | 44% |
| May 13, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $30 | 44% |
| Mar 6, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $30 | 44% |
| Jan 8, 2025 | Northland Capital Markets | maintain | Outperform → Outperform | $31 | 50% |
| Dec 19, 2024 | Benchmark | reiterate | Buy → Buy | $30 | 54% |
| Dec 13, 2024 | Keybanc | maintain | Overweight → Overweight | $33 | 53% |
| Nov 18, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $27 | 44% |
| Nov 13, 2024 | TD Cowen | maintain | Buy → Buy | $31 | 54% |
| Nov 13, 2024 | Craig-Hallum | maintain | Buy → Buy | $32 | 54% |
| Sep 30, 2024 | HC Wainwright & Co. | initiate | — → Buy | $29 | 44% |
| Aug 12, 2024 | Craig-Hallum | maintain | Buy → Buy | $30 | 54% |
| Aug 9, 2024 | Northland Capital Markets | maintain | Outperform → Outperform | $28 | 50% |
| Jul 17, 2024 | TD Cowen | maintain | Buy → Buy | $26 | 54% |
| May 13, 2024 | Benchmark | upgrade | Hold → Buy | $25 | 54% |
| Apr 4, 2024 | Jefferies | initiate | — → Buy | $22 | 52% |
| Aug 10, 2023 | Craig-Hallum | maintain | Buy → Buy | $23 | 54% |
| Aug 9, 2023 | TD Cowen | maintain | Outperform → Outperform | $25 | 54% |
| Aug 9, 2023 | Lake Street | maintain | Buy → Buy | $25 | 47% |
| Jul 17, 2023 | Stephens & Co. | maintain | Overweight → Overweight | $29 | 54% |
| Jul 11, 2023 | Craig-Hallum | initiate | — → Buy | $29 | 54% |
| Mar 17, 2023 | Stephens & Co. | maintain | — → Overweight | $27 | 54% |
| Mar 6, 2023 | Oppenheimer | reiterate | — → Outperform | $28 | 52% |
| May 10, 2022 | Stephens & Co. | maintain | — → Overweight | $40 | 54% |
| May 10, 2022 | Keybanc | maintain | — → Overweight | $30 | 53% |
| Apr 25, 2022 | Oppenheimer | upgrade | Perform → Outperform | $28 | 52% |
| Aug 13, 2021 | Keybanc | maintain | — → Overweight | $60 | 53% |
| May 14, 2021 | Benchmark | downgrade | Buy → Hold | $0 | 54% |
| Mar 23, 2021 | Benchmark | upgrade | Hold → Buy | $54 | 54% |
| Mar 23, 2021 | Keybanc | maintain | — → Overweight | $50 | 53% |
| Nov 10, 2020 | Keybanc | initiate | — → Overweight | $40 | 53% |
| Sep 22, 2020 | Oppenheimer | downgrade | Outperform → Perform | $0 | 52% |
| Sep 18, 2020 | Cowen & Co. | initiate | — → Outperform | $33 | — |
| Aug 11, 2020 | Benchmark | downgrade | Buy → Hold | $0 | 54% |
| May 4, 2020 | B. Riley Securities | maintain | — → Buy | $22 | 55% |
| Mar 23, 2020 | HC Wainwright & Co. | maintain | — → Buy | $17 | 44% |
| Mar 12, 2020 | B. Riley Securities | maintain | — → Buy | $24 | 55% |
| Feb 24, 2020 | Lake Street | initiate | — → Buy | $25 | 47% |
| Feb 19, 2020 | Benchmark | initiate | — → Buy | $24 | 54% |
| Feb 6, 2020 | B. Riley Securities | initiate | — → Buy | $27 | 55% |
| Dec 16, 2019 | HC Wainwright & Co. | reiterate | — → Buy | $26 | 44% |
| Nov 21, 2019 | Oppenheimer | initiate | — → Outperform | $22 | 52% |
| Sep 4, 2019 | Northland Capital Markets | maintain | — → Outperform | $22 | 50% |
Price Target Trend
May 12, 2026 Latest: $31 Oct 25, 2026
EPS Estimates
+1q $0.08
Lo: $0.08 Hi: $0.08
1 analysts 0y $0.25
Lo: $0.25 Hi: $0.25
1 analysts 0q $0.07
Lo: $0.07 Hi: $0.07
1 analysts +1y $0.33
Lo: $0.33 Hi: $0.33
1 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days